InvestorsHub Logo
Followers 29
Posts 2120
Boards Moderated 0
Alias Born 11/30/2017

Re: None

Monday, 03/04/2019 9:16:07 AM

Monday, March 04, 2019 9:16:07 AM

Post# of 4273
Zero debt if the $200 million is allocated properly.
The sale of Synergy's assets, including all rights to TRULANCE® (plecanatide), dolcanatide and related intellectual property, is now expected to close on or about March 5, 2019 (DONE)
Could be a fresh start?.. time will tell..

My Due diligence will not be obliterated 4 legalis proposita.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.